DAVID A GUBIN MD NPI 1235164286

NPI Details

David A Gubin, MD is an urology in Memphis, TN with 33 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. David A Gubin, MD NPI is 1235164286. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

6029 WALNUT GROVE RD.
SUITE 300
MEMPHIS, TN
ZIP 38120
Phone: (901) 767-8158
Fax: (901) 767-1555

The NPI 1235164286 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Automated urinalysis test (HCPCS:81003)
• Leuprolide injectable, camcevi, 1 mg (HCPCS:J1952)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope (HCPCS:52351)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Analysis for detection of tumor marker (HCPCS:86316)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Testosterone (hormone) level, total (HCPCS:84403)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Simple change of bladder tube (HCPCS:51705)
• Insertion of needle into vein (3 years or older) (HCPCS:36410)
• Blood creatinine level (HCPCS:82565)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Aspiration of bladder with insertion of bladder tube to skin (HCPCS:51102)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Biopsy and/or destruction of growth of ureter or kidney using an endoscope (HCPCS:52354)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Biopsy of prostate gland (HCPCS:55700)
• Removal or manipulation of stone in ureter or kidney using an endoscope (HCPCS:52352)
• Biopsy of bladder using an endoscope (HCPCS:52204)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Crushing of stone of ureter using an endoscope (HCPCS:52353)
• Complete removal of remaining or regrown prostate tissue with control of bleeding using an endoscope (HCPCS:52630)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Ct scan of abdomen before and after contrast (HCPCS:74170)
• Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies (HCPCS:51729)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Insertion of sacral nerve neurostimulator electrode array (HCPCS:64561)
• Biopsy of prostate gland (HCPCS:55700)
• Insertion of peripheral or gastric neurostimulator generator (HCPCS:64590)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm (HCPCS:52234)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Sex hormone binding globulin (protein) level (HCPCS:84270)
• Testosterone (hormone) level, free (HCPCS:84402)
• Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming (HCPCS:95972)
• Complete ultrasound of penis artery and vein blood flow (HCPCS:93980)
• Imaging guidance for procedure, 60 minutes or less (HCPCS:76000)
• Injection procedure to cause erection (HCPCS:54235)
• Creation of sling around urethra in female to control leakage (HCPCS:57288)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 7/11/2006 and was last updated on 7/25/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.